Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights significant improvements in financial metrics, including reduced losses and improved cash utilization. The company showcases optimism with strong guidance for 2026, especially in ESS and drones. The Q&A section reveals some concerns, such as delays in EV projects, but overall sentiment remains positive due to strategic focus on high-growth areas like ESS and drones, and the potential of the Molecular Universe platform. The positive guidance and financial improvements suggest a likely positive stock price movement in the short term.
Full Year Revenue 2025 $21 million, compared to a little over $2 million for 2024, representing nearly tenfold growth. This growth was driven by contributions from services agreements with Honda and Hyundai and 3.5 months of revenue from the acquisition of UZ Energy for the ESS business.
Fourth Quarter Revenue 2025 $4.6 million, representing a $2.6 million or 124% increase year-over-year. Growth was impacted by logistics constraints that delayed shipments, pushing approximately $1.5 million of revenue to Q1 2026.
Q4 GAAP Gross Margin 2025 11.3%, driven by a higher mix of ESS product sales, which carry a lower margin profile relative to service revenue.
Full Year GAAP Gross Margin 2025 53.8%, with non-GAAP gross margin at 55.7%. Margins are expected to vary as revenue mix evolves.
Q4 GAAP Operating Expenses 2025 $18.2 million, a 40% decrease year-over-year, reflecting cost optimization efforts.
Full Year GAAP Operating Expenses 2025 $93.9 million, a 15% decrease year-over-year, reflecting progress in cost structure optimization.
Adjusted EBITDA Q4 2025 Loss of $13.8 million, a 40% improvement compared to a loss of $23.2 million in Q4 2024.
Adjusted EBITDA Full Year 2025 Loss of $52.6 million, a 23% improvement compared to a loss of $81.5 million in 2024.
GAAP Net Loss Q4 2025 $17 million or $0.05 loss per share, an improvement from $34.5 million or $0.11 loss per share in Q4 2024.
GAAP Net Loss Full Year 2025 $73 million or $0.22 loss per share, an improvement from $100.2 million or $0.31 loss per share in 2024.
Non-GAAP Net Loss Q4 2025 $11.8 million or $0.04 loss per share, an improvement from $19.9 million or $0.06 loss per share in Q4 2024.
Non-GAAP Net Loss Full Year 2025 $53.2 million or $0.16 loss per share, an improvement from $66.4 million or $0.21 loss per share in 2024.
Cash Utilized for Operations Full Year 2025 $58.4 million, reflecting improved cash utilization consistent with adjusted EBITDA progress.
Liquidity Position End of 2025 $200 million, at the top end of the previously communicated range of $195 million to $200 million.
Revenue growth: Full year revenue of $21 million in 2025, up from $2 million in 2024, driven by services agreements with Honda and Hyundai and acquisition of UZ Energy.
Molecular Universe: Development of the Molecular Universe platform to accelerate battery technology adoption and improve battery health monitoring.
ESS business: Entry into the ESS market through UZ Energy acquisition, serving global customers and integrating AI features for battery health prediction.
Drone batteries: Focus on high energy and power density batteries for drones, with plans to convert South Korea facility for drone battery production.
Materials business: Joint venture with Hisun to produce electrolyte materials for various applications, leveraging Molecular Universe discoveries.
ESS market expansion: Expansion into North America, in addition to existing markets in Australia, Europe, and the Middle East.
Drone market: Targeting U.S. defense drones market with high-performance batteries.
Cost optimization: Reduced operating expenses by 15% year-over-year in 2025, with further reductions planned for 2026.
Revenue diversification: Three revenue-generating units: ESS, drones, and materials, with ESS as the largest near-term driver.
CapEx-light model: Maintaining a CapEx-light business model to optimize cost structure.
AI integration: Leveraging AI for safety, manufacturing, and battery health monitoring.
NDAA compliance: Converting South Korea facility to produce NDAA-compliant drone batteries and exploring additional capacity in Southeast Asia.
Molecular Universe monetization: Exploring ways to unlock the value of the Molecular Universe platform as a standalone business.
Logistics Constraints: Delayed shipments at the end of 2025 resulted in approximately $1.5 million of revenue being pushed to the first quarter of 2026, impacting financial performance.
ESS Hardware Margins: The ESS hardware business, which represents the largest share of revenue, operates at a low gross margin of around 15%, potentially limiting profitability.
Drone Manufacturing Transition: The conversion of the South Korea facility from EV cells to NDAA-compliant drone cells involves capital expenditures and operational risks, including potential delays or cost overruns.
Supply Chain Compliance: Drone batteries require compliance with the National Defense Authorization Act (NDAA), which may limit supply chain flexibility and increase costs.
Revenue Dependency on ESS: The ESS business is the largest near-term revenue driver, creating dependency on its performance and market conditions.
Economic Uncertainties: Economic conditions and logistics constraints could impact revenue growth and operational efficiency.
Cost Structure Optimization: While operating expenses have decreased, further reductions may be challenging without impacting strategic investments, particularly in the Molecular Universe platform.
Market Competition: The company faces competitive pressures in the ESS, drone, and materials markets, which could impact market share and pricing.
Regulatory and Compliance Risks: Compliance with various regulations, including NDAA for drones, adds complexity and potential risks to operations.
CapEx-Light Model Limitations: The CapEx-light model may limit the company's ability to scale rapidly or respond to unexpected demand surges.
Revenue Growth: For full year 2026, revenue is expected to be in the range of $30 million to $35 million, representing approximately 43% to 67% growth over full year 2025 revenue.
ESS Business: The ESS hardware business, expected to represent the largest share of revenue in 2026, is projected to operate at around 15% gross margin. The company plans to expand margins over time by bundling hardware and software and increasing the operating system attach rate.
Drone Sales Business: The drone sales business is expected to achieve gross margins north of 20% as volumes build through the year. The company plans to convert its South Korea facility to manufacture NDAA-compliant cells for drones and is exploring additional manufacturing capacities in Southeast Asia.
Materials Business: The materials business, which will sell electrolyte materials through a joint venture with Hisun, is expected to carry a margin profile in the 10% to 20% range.
Consolidated Gross Margin: On a blended basis, consolidated gross margin is expected to be around 15%, with potential for improvement year-over-year as the business scales.
Operating Expenses: Operating expenses for full year 2026 are expected to decrease by approximately 15% from 2025 levels. The company plans to continue investing in the Molecular Universe platform while maintaining financial discipline.
Capital Expenditures: Capital expenditures for 2026 are expected to remain in the single-digit million range, primarily directed towards converting the South Korea facility for drone cells and evaluating contract manufacturing capacities in Southeast Asia.
Share repurchases: The company returned $1.6 million to shareholders through share repurchases during 2025.
The earnings call highlights significant improvements in financial metrics, including reduced losses and improved cash utilization. The company showcases optimism with strong guidance for 2026, especially in ESS and drones. The Q&A section reveals some concerns, such as delays in EV projects, but overall sentiment remains positive due to strategic focus on high-growth areas like ESS and drones, and the potential of the Molecular Universe platform. The positive guidance and financial improvements suggest a likely positive stock price movement in the short term.
The earnings call highlights several positive aspects: a reduction in net loss, a strong liquidity position, and share repurchases. Additionally, the Q&A reveals optimism about the growth potential of UZ Energy and Molecular Universe, with increasing trials and enterprise interest. However, management's vague response on liquidity projections is a minor concern. Overall, the positive developments in market strategy and financial health, along with optimistic guidance for UZ Energy, suggest a positive stock price movement in the short term.
SES AI's earnings call indicates a positive outlook with record revenue, strong gross margins, and a robust liquidity position. The launch of the Molecular Universe platform and strategic acquisition of UZ Energy bolster growth prospects. Share repurchases enhance shareholder value. However, uncertainties in strategic execution and competitive pressures exist. Overall, the positive elements outweigh the risks, suggesting a positive stock price reaction.
The earnings call highlights strong financial performance with record revenue and high gross margins, a solid liquidity position, and a share buyback program, all of which are positive indicators. However, competitive pressures and regulatory issues pose risks. The Q&A session did not reveal significant negative sentiments, and the share buyback is seen as efficient capital allocation. Despite some unclear responses from management, the overall sentiment is positive, suggesting a likely stock price increase of 2% to 8%.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.